Krzeminski Laurel J purchased $25K of LMB (indirect holdings)

JPMorgan downgraded Limbach Holdings (LMB) to Underweight, lowering its price target to $50 from $60. The stock is near its 52-week low at $42.75. Five analysts revised earnings downward. The company reported Q2 2026 earnings and revenue below expectations, with near-term margin pressures cited. Stifel lowered its price target to $86 but maintained a Buy rating.

Limbach Holdings said it acquired CYMCOR for about $30 million to expand in data center infrastructure services. The deal, funded via cash and borrowings under its revolving credit facility, is expected to add about $12 million of professional services revenue and $4 million of adjusted EBITDA in 2027. CYMCOR manages projects with over $8 billion in budgets.

Limbach (LMB) reported Q2 revenue of $173.5M, below analysts’ $177.3M estimate, and adjusted EPS of $0.64 versus $0.93 expected. Adjusted EBITDA was $13.94M versus $19.6M expected, with operating margin at 4.3%. CEO Michael McCann cited project timing and softer healthcare and institutional demand. Full-year revenue guidance was raised to $775M midpoint, but EBITDA guidance was below estimates.

Limbach Holdings (NASDAQ: LMB) reported Q2 revenue up 35.3% to $45 million, with organic GCR revenue up 12% and acquisition-related revenue up 23.3%. Gross margin fell to 21.5% from 28%, and net income dropped 38.8% to $4.7 million. Operating cash flow rose to $18.7 million. The company raised 2026 revenue guidance to $760M-$790M and lowered adjusted EBITDA to $78M-$84M.

Limbach (LMB) shares fell 31.5% after the company reported mixed Q2 2026 results and guidance below expectations. Revenue was $173.5M vs $177.3M consensus. Adjusted EPS was $0.64, 30.9% below forecasts. Full-year revenue guidance rose, but EBITDA guidance of $81M missed Wall Street.

Limbach (NASDAQ:LMB) reported Q2 CY2026 revenue of $173.5 million, up 21.9% year on year but below Wall Street expectations. The company guided full-year revenue to $775 million at the midpoint, 4.3% above analysts’ estimates. Non-GAAP EPS was $0.64, down from $0.93 a year earlier and 30.9% below consensus. Shares fell 10.1% to $69.16.